Autologous bone marrow-derived mononuclear stem cells for treatment of temporal lobe epilepsy

The aim of this study was to evaluate the safety of transplantation of autologous bone marrow mononuclear stem cells and to assess their potential therapeutic benefits toward treatment of  temporal lobe refractory epilepsy.